Webinars
Disruptive Innovations Shaping the Future of Adoptive Cell Therapies
Life Sciences
×
The therapeutic potential of cell therapies is an established fact, but whether will they be able to overcome challenges posed by Solid Tumors remains a question. With innovative strategies, many types of cell therapies are being developed by Industry and academia with a focus on succeeding in Solid tumors. Engineered receptors (like CAR/ TCR), novel gene-editing techniques (CRISPR/ Transposons/ lentiviral, etc), scaling processes, etc are being developed to actualize the dream of transforming patients’ treatment through cell therapies.
Let’s explore the upcoming disruptive innovations that will bring about a paradigm shift in the development and success of cell therapies in solid tumors.
FutureBridge’s Oncology Analysts in this webinar cover:
- Residual unmet needs that are unlikely to be answered by upcoming platforms
- The focus of current innovations on improving cell therapies
- What innovation trend is driving the technological reform in cell therapies?
- Reproducible quick manufacturing and scaling platforms of cell therapies
- Innovative platforms that hold the potential to push cell therapy toward success in Solid Tumors
- FutureBridge’s vision and take on industry transformation
Need a thought partner?
Share your focus area or question to engage with our Analysts through the Business Objectives service.
Submit My Business ObjectiveOur Clients
Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.
- © 2021 Cheers Interactive (India) Private Limited. All rights reserved. FutureBridge ® is a registered trademark of Cheers Interactive (India) Private Limited.
